The Biden Administration issued the Fall 2022 Unified Agenda of Regulatory and Deregulatory Actions (the Unified Agenda) earlier this month.
Typically published twice a year in the spring and the fall by the Office of Information and Regulatory Affairs (OIRA), the Unified Agenda includes contributions from federal agencies regarding planned short- and long-term rulemaking actions. Short-term actions are those activities that an agency expects to complete within the next 12 months. Long-term activities are under development, but an agency does not expect to complete action within 12 months.
In the current Unified Agenda, the U.S. Food and Drug Administration (FDA) lists 74 …
